6-((1-(2-(3-fluoro-6-methoxy-1,5-naphthyridin-4-yl)ethyl)-2-oxabicyclo[2.2.2]octan-4-ylamino)methyl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one

InChIKey	`BCOYDHFZZXSZFA-UHFFFAOYSA-N`
Compound Name	6-((1-(2-(3-fluoro-6-methoxy-1,5-naphthyridin-4-yl)ethyl)-2-oxabicyclo[2.2.2]octan-4-ylamino)methyl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one
Canonical SMILES	`COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	6.51
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q12809	KCNH2	Homo sapiens	Human	PF00027 PF00520 PF13426	6.2	IC50	ChEMBL;BindingDB
P0A0K8	gyrB	Staphylococcus aureus	Pathogen	PF00204 PF00986 PF02518 PF01751	6.7	IC50	ChEMBL
P20831	gyrA	Staphylococcus aureus	Pathogen	PF03989 PF00521	6.7	IC50	ChEMBL